Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Apr 11;11(4):820.
doi: 10.3390/nu11040820.

Effects of Lactobacillus plantarum PS128 on Children with Autism Spectrum Disorder in Taiwan: A Randomized, Double-Blind, Placebo-Controlled Trial

Affiliations
Randomized Controlled Trial

Effects of Lactobacillus plantarum PS128 on Children with Autism Spectrum Disorder in Taiwan: A Randomized, Double-Blind, Placebo-Controlled Trial

Yen-Wenn Liu et al. Nutrients. .

Abstract

This four-week, randomized, double-blind, placebo-controlled study investigated the effects of Lactobacillus plantarum PS128 (PS128) on boys with autism spectrum disorder (ASD) aged 7-15 in Taiwan. All subjects fulfilled the criteria for ASD diagnosis of DSM-V and the Autism Diagnostic Interview-Revised (ADI-R). Questionnaires used for the primary outcome measure include the Autism Behavior Checklist-Taiwan version (ABC-T), the Social Responsiveness Scale (SRS) and the Child Behavior Checklist (CBCL). The Swanson, Nolan, and Pelham-IV-Taiwan version (SNAP-IV) and the Clinical Global Impression-improvement (CGI-I) were used for the secondary outcome measure. The results showed that PS128 ameliorated opposition/defiance behaviors, and that the total score of SNAP-IV for younger children (aged 712) improved significantly compared with the placebo group. Additionally, several elements were also notably improved in the PS128 group after 28-day consumption of PS128. Further studies are needed to better clarify the effects of PS128 for younger children with ASD on broader symptoms.

Keywords: Lactobacillus plantarum PS128; anxiety; autism spectrum disorder (ASD); hyperactivity; psychobiotic.

PubMed Disclaimer

Conflict of interest statement

Y.-C.T. owns stock in Bened Biomedical Co., Ltd. Other authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Trial profile.

References

    1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders (DSM-5®) 5th ed. American Psychiatric Publishing; Washington, DC, USA: 2013.
    1. Veenstra-Vanderweele J., Christian S.L., Cook E.H., Jr. Autism as a paradigmatic complex genetic disorder. Annu. Rev. Genom. Hum. Genet. 2004;5:379–405. doi: 10.1146/annurev.genom.5.061903.180050. - DOI - PubMed
    1. Kuo P.H., Chuang L.C., Su M.H., Chen C.H., Wu J.Y., Yen C.J., Wu Y.Y., Liu S.K., Chou M.C., Chou W.J., et al. Genome-wide association study for autism spectrum disorder in Taiwanese Han population. PLoS ONE. 2015;10:e0138695. doi: 10.1371/journal.pone.0138695. - DOI - PMC - PubMed
    1. Moosa A., Shu H., Sarachana T., Hu V.W. Are endocrine disrupting compounds environmental risk factors for autism spectrum disorder? Horm. Behav. 2017 doi: 10.1016/j.yhbeh.2017.10.003. - DOI - PMC - PubMed
    1. Strasser L., Downes M., Kung J., Cross J.H., De Haan M. Prevalence and risk factors for autism spectrum disorder in epilepsy: A systematic review and meta-analysis. Dev. Med. Child Neurol. 2017 doi: 10.1111/dmcn.13598. - DOI - PubMed

Publication types